Perrone RD - Search Results

1

Autosomal dominant polycystic kidney disease.

Cornec-Le Gall E, Alam A, Perrone RD. Cornec-Le Gall E, et al. Among authors: perrone rd. Lancet. 2019 Mar 2;393(10174):919-935. doi: 10.1016/S0140-6736(18)32782-X. Epub 2019 Feb 25. Lancet. 2019. PMID: 30819518 Review.

2

Cyst function in polycystic kidney disease: nongradient cysts.

Perrone RD, McLaughlin ML. Perrone RD, et al. Clin Nephrol. 1989 Sep;32(3):113-8. Clin Nephrol. 1989. PMID: 2791361

3

Continuous epithelial cell lines from ADPKD liver cysts exhibit characteristics of intrahepatic biliary epithelium.

Perrone RD, Grubman SA, Rogers LC, Lee DW, Moy E, Murray SL, Torres VE, Jefferson DM. Perrone RD, et al. Am J Physiol. 1995 Sep;269(3 Pt 1):G335-45. doi: 10.1152/ajpgi.1995.269.3.G335. Am J Physiol. 1995. PMID: 7573443

4

Matrix metalloproteinase activity in human intrahepatic biliary epithelial cell lines from patients with autosomal dominant polycystic kidney disease.

Murray SL, Grubman SA, Perrone RD, Rojkind M, Moy E, Lee DW, Jefferson DM. Murray SL, et al. Among authors: perrone rd. Connect Tissue Res. 1996;33(4):249-56. doi: 10.3109/03008209609028882. Connect Tissue Res. 1996. PMID: 8834442

5

Autosomal dominant polycystic kidney disease decreases anion exchanger activity.

Perrone RD, Grubman SA, Murray SL, Lee DW, Alper SL, Jefferson DM. Perrone RD, et al. Am J Physiol. 1997 May;272(5 Pt 1):C1748-56. doi: 10.1152/ajpcell.1997.272.5.C1748. Am J Physiol. 1997. PMID: 9176168

6

Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: contribution of extrarenal complications to mortality.

Perrone RD, Ruthazer R, Terrin NC. Perrone RD, et al. Am J Kidney Dis. 2001 Oct;38(4):777-84. doi: 10.1053/ajkd.2001.27720. Am J Kidney Dis. 2001. PMID: 11576881

7

National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G; National Kidney Foundation. Levey AS, et al. Among authors: perrone rd. Ann Intern Med. 2003 Jul 15;139(2):137-47. doi: 10.7326/0003-4819-139-2-200307150-00013. Ann Intern Med. 2003. PMID: 12859163 Free article.

8

The effect of angiotensin-converting-enzyme inhibitors on progression of advanced polycystic kidney disease.

Jafar TH, Stark PC, Schmid CH, Strandgaard S, Kamper AL, Maschio G, Becker G, Perrone RD, Levey AS; ACE Inhibition in Progressive Renal Disease (AIPRD) Study Group. Jafar TH, et al. Among authors: perrone rd. Kidney Int. 2005 Jan;67(1):265-71. doi: 10.1111/j.1523-1755.2005.00077.x. Kidney Int. 2005. PMID: 15610250 Free article.

9

Hypertension in individuals at risk for autosomal dominant polycystic kidney disease: to screen or not to screen?

Perrone RD, Miskulin DC. Perrone RD, et al. Am J Kidney Dis. 2005 Sep;46(3):557-9. doi: 10.1053/j.ajkd.2005.07.016. Am J Kidney Dis. 2005. PMID: 16129219 No abstract available.

10

Imaging progression in polycystic kidney disease.

Perrone R. Perrone R. N Engl J Med. 2006 May 18;354(20):2181-3. doi: 10.1056/NEJMe068078. N Engl J Med. 2006. PMID: 16707757 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results